Home Weight loss (GLP-1) By state Michigan
Michigan's 2026 Medicaid GLP-1 Limits: 8 programs ship to MI
Michigan residents have watched GLP-1 coverage shrink three times in two years. Blue Cross Blue Shield of Michigan dropped weight-loss coverage for many groups in 2025, then Medicaid and the state employee plan cut back in 2026. Here is who is still covered and what the rest pay online. The lowest price we found from a program that ships to Michigan: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Michigan at a glance
- Michigan Medicaid
- Limited coverage
- State employee plan
- Does not cover for weight loss
- Adults with obesity
- 35.1% (2025)
- Programs we compare that ship to MI
- 8 of 22
Online GLP-1 programs for Michigan, cheapest first
Programs that ship to Michigan. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in Michigan: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Michigan: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
Three Michigan cutbacks in two years
Blue Cross Blue Shield of Michigan went first. For fully insured large-group members, it stopped covering Saxenda, Wegovy and Zepbound for weight loss on January 1, 2025, or at the group's 2025 renewal. Self-funded employers choose for themselves. Diabetes drugs such as Ozempic and Mounjaro stayed covered. Bloomberg reported close to 10,000 members were affected.
Medicaid came next. Michigan's budget cut $240 million from Medicaid drug spending by limiting weight-loss GLP-1s, starting January 1, 2026, under MDHHS letter L 25-73. The same day, the State Health Plan PPO and HDHP stopped covering Saxenda, Wegovy and Zepbound for weight management. Two of the biggest public payers in the state changed course on a single date, and diabetes coverage was left alone in both.
That leaves Michiganders without coverage paying cash, from Grand Rapids to the Upper Peninsula. The good news is that cash prices have dropped a lot. Online programs licensed in Michigan sell compounded semaglutide and tirzepatide with medication and shipping in the monthly price (ask whether the visit is included), and Maximus sells brand-name drugs too. Pills are an option for people who would rather skip weekly shots, and a single monthly price makes budgeting easier.
- Blue Cross Blue Shield of Michigan and Blue Care Network ended weight-loss GLP-1 coverage for fully insured large-group members starting January 1, 2025. (bcbsm.com)
- Michigan's budget limited Medicaid weight-loss GLP-1 coverage to people with morbid obesity, cutting $240 million (Bridge Michigan). (bridgemi.com)
- MDHHS letter L 25-73 set the new Medicaid criteria effective January 1, 2026. (michigan.gov)
- Michigan's State Health Plan PPO and HDHP no longer cover Saxenda, Wegovy and Zepbound for weight management since January 1, 2026. (michigan.gov)
- 35.1% of Michigan adults had obesity in 2025 (CDC). (cdc.gov)
- Under MDHHS letter L 25-73 (effective January 1, 2026), Michigan Medicaid covers weight-loss GLP-1s only for morbid obesity, after a trial and failure of preferred anti-obesity agents, and only as a measure to avert bariatric surgery. (medresearch.umich.edu)
- Priority Health told providers that from January 1, 2026, Michigan Medicaid criteria for Wegovy and Zepbound include non-weight-loss uses such as cardiovascular risk reduction and severe obstructive sleep apnea, and that current approvals continue until they expire. (priorityhealth.com)
- Michigan had the highest Medicare Advantage penetration of any state in 2025: 63.4% overall (RUPRI analysis of CMS data). (rupri.public-health.uiowa.edu)
- Michigan retirees in Medicare drug plans can use the federal GLP-1 Bridge from July 1, 2026 to December 31, 2027: Wegovy, Foundayo or the Zepbound KwikPen for $50 a fill, with prior authorization and BMI criteria. (cms.gov)
Reading L 25-73: BMI 40, failed drugs and the surgery test
The new Medicaid bar is high. MDHHS letter L 25-73 limits Saxenda, liraglutide, Wegovy and Zepbound for weight loss to patients with morbid obesity. The doctor must document a trial and failure of the preferred non-GLP-1 weight-loss drugs, and must attest that the GLP-1 is needed to avoid more costly bariatric surgery.
Members who started 2026 on an approved GLP-1 did not lose it overnight. Their coverage runs to the end of the current authorization, and renewals must meet the new test. Priority Health, one of the Medicaid health plans, told providers that Wegovy and Zepbound criteria now also cover non-weight uses, such as lowering heart attack and stroke risk or treating severe sleep apnea, with prior authorization for every use.
The Medicare GLP-1 Bridge in the state with the most Medicare Advantage
Michigan leads the country on one Medicare measure. A University of Iowa RUPRI analysis of CMS data found that 63.4% of Michigan's Medicare beneficiaries were in Medicare Advantage plans in 2025, the highest rate of any state, in cities and rural counties alike. That matters for the federal GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027 and offers Wegovy, Foundayo and the Zepbound KwikPen for a $50 copay for each one-month supply.
The Bridge works through Medicare drug coverage and needs prior authorization. CMS sets the bar at a BMI of 35, or 30 with conditions such as uncontrolled high blood pressure, or 27 with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease. People with type 2 diabetes use their regular Part D benefit instead. Your prescriber files the Bridge prior authorization with CMS's central processor, not with your plan; ask your doctor's office to start it before you pay cash.
GLP-1 in Michigan: questions
Does Blue Cross Blue Shield of Michigan cover Wegovy for weight loss?
For fully insured large-group plans, no, since January 1, 2025 or the group's 2025 renewal. Self-funded employer plans decide for themselves, so check with your HR team. Ozempic and Mounjaro remain covered for type 2 diabetes. If your plan excludes weight-loss drugs, compare the cash programs on this page.
Who still qualifies for a GLP-1 under Michigan Medicaid?
Since January 1, 2026, Michigan Medicaid covers weight-loss GLP-1s only for people with morbid obesity whose doctor documents that preferred non-GLP-1 weight-loss drugs have failed and that the drug is needed to avoid bariatric surgery. Members approved before the change kept coverage until their current authorization ended. Others can pay cash through online programs.
Are GLP-1s covered for Michigan state employees in 2026?
Not for weight management. The State Health Plan PPO and HDHP dropped Saxenda, Wegovy and Zepbound for weight loss on January 1, 2026. GLP-1s for diabetes are still covered. State workers can compare online programs below, where the monthly price includes the medication and shipping.
Can I get a GLP-1 shipped to the Upper Peninsula?
Yes. Online programs licensed in Michigan ship to any address in the state, including the U.P. You complete the medical intake online and never drive to a clinic. Each program on this page is confirmed to serve Michigan.
What is the cheapest GLP-1 option in Michigan without insurance?
Compounded semaglutide and tirzepatide programs are usually cheapest, and several keep one price at every dose. In November 2026 Lttl charged $99 a month for semaglutide and Maximus listed tirzepatide from $99.99 on a 12-month plan. Brand-name drugs from Maximus cost more. Compare the price at the dose you expect to stay on, not only the first month.
Does Michigan Medicaid cover Wegovy or Zepbound for heart risk or sleep apnea?
It can, with prior authorization. Michigan Medicaid health plans say Wegovy and Zepbound criteria now include non-weight uses, such as lowering the risk of heart attack and stroke or treating severe sleep apnea. Weight loss alone needs morbid obesity plus documented failed treatments.
Can I get Wegovy through Medicare in Michigan?
Possibly, through the federal GLP-1 Bridge from July 1, 2026 to December 31, 2027. It charges a $50 copay for each one-month supply for eligible Medicare drug plan members who meet BMI rules and get prior authorization. Your prescriber files the request with CMS's Bridge processor, whichever Medicare drug plan you have.
See programs for Michigan All states
Sources: priorityhealth.com · cdc.gov · michigan.gov